Suraksha Diagnostic [SURAKSHA] vs Qualitek Labs [QLL] Detailed Stock Comparison

Suraksha Diagnostic Ltd.

NSE

Qualitek Labs Ltd.

BSE

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Suraksha Diagnostic Ltd. wins in 9 metrics, Qualitek Labs Ltd. wins in 7 metrics, with 0 ties. Suraksha Diagnostic Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Suraksha Diagnostic Ltd.	Qualitek Labs Ltd.	Better
P/E Ratio (TTM)	45.27	37.58	Qualitek Labs Ltd.
Price-to-Book Ratio	6.37	2.57	Qualitek Labs Ltd.
Debt-to-Equity Ratio	51.30	50.78	Qualitek Labs Ltd.
PEG Ratio	2.05	N/A	N/A
EV/EBITDA	33.72	26.91	Qualitek Labs Ltd.
Profit Margin (TTM)	11.32%	8.97%	Suraksha Diagnostic Ltd.
Operating Margin (TTM)	17.32%	15.25%	Suraksha Diagnostic Ltd.
EBITDA Margin (TTM)	17.32%	15.25%	Suraksha Diagnostic Ltd.
Return on Equity	15.14%	12.27%	Suraksha Diagnostic Ltd.
Return on Assets (TTM)	9.54%	7.21%	Suraksha Diagnostic Ltd.
Free Cash Flow (TTM)	$213.35M	$-128.53M	Suraksha Diagnostic Ltd.
1-Year Return	-18.17%	43.88%	Qualitek Labs Ltd.
Price-to-Sales Ratio (TTM)	5.00	5.12	Suraksha Diagnostic Ltd.
Enterprise Value	$15.49B	$4.38B	Suraksha Diagnostic Ltd.
EV/Revenue Ratio	5.27	6.24	Suraksha Diagnostic Ltd.
Gross Profit Margin (TTM)	88.84%	N/A	N/A
Revenue per Share (TTM)	$56	$79	Qualitek Labs Ltd.
Earnings per Share (Diluted)	$6.24	$9.58	Qualitek Labs Ltd.
Beta (Stock Volatility)	N/A	-0.11	N/A

Suraksha Diagnostic Ltd. vs Qualitek Labs Ltd. Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Suraksha Diagnostic Ltd.	0.07%	-2.70%	-12.26%	6.83%	-5.81%	-1.79%
Qualitek Labs Ltd.	-0.04%	0.22%	15.46%	32.25%	2.48%	4.30%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Suraksha Diagnostic Ltd.	-18.17%	-35.76%	-35.76%	-35.76%	-35.76%	-35.76%
Qualitek Labs Ltd.	43.88%	141.56%	141.56%	141.56%	141.56%	141.56%

Performance & Financial Health Analysis: Suraksha Diagnostic Ltd. vs Qualitek Labs Ltd.

Metric	SURAKSHA	QLL
Market Information
Market Cap i	₹14.71B	₹3.59B
Market Cap Category	Small cap	Small cap
10 Day Avg. Volume i	21,227	8,240
90 Day Avg. Volume i	30,913	7,253
Last Close	₹268.25	₹409.90
52 Week Range	₹224.10 - ₹352.50	₹258.55 - ₹458.95
% from 52W High	-23.90%	-10.69%
All-Time High	₹449.00 (Dec 02, 2024)	₹458.95 (Sep 19, 2025)
% from All-Time High	-40.26%	-10.69%
Growth Metrics
Quarterly Revenue Growth	0.29%	N/A
Quarterly Earnings Growth	0.22%	N/A
Financial Health
Profit Margin (TTM) i	0.11%	0.09%
Operating Margin (TTM) i	0.17%	0.15%
Return on Equity (TTM) i	0.15%	0.12%
Debt to Equity (MRQ) i	51.30	50.78
Cash & Liquidity
Book Value per Share (MRQ)	₹44.35	₹140.22
Cash per Share (MRQ)	₹8.35	₹0.46
Operating Cash Flow (TTM) i	₹365.13M	₹104.99M
Levered Free Cash Flow (TTM) i	₹318.24M	₹-329,006,240
Dividends
Last 12-Month Dividend Yield i	N/A	N/A
Last 12-Month Dividend i	N/A	N/A

Valuation & Enterprise Metrics Analysis: Suraksha Diagnostic Ltd. vs Qualitek Labs Ltd.

Metric	SURAKSHA (Apr 26, 2026)	QLL (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i	45.27	37.58
Forward P/E i	36.69	N/A
PEG Ratio i	2.05	N/A
Price to Sales (TTM) i	5.00	5.12
Price to Book (MRQ) i	6.37	2.57
Market Capitalization
Market Capitalization i	₹14.71B	₹3.59B
Enterprise Value i	₹15.49B	₹4.38B
Enterprise Value Metrics
Enterprise to Revenue i	5.27	6.24
Enterprise to EBITDA i	33.72	26.91
Risk & Other Metrics
Beta i	N/A	-0.11
Book Value per Share (MRQ) i	₹44.35	₹140.22

Financial Statements Comparison: Suraksha Diagnostic Ltd. vs Qualitek Labs Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

Metric	SURAKSHA (2025)	QLL (2025)
Revenue/Sales i	2.52B	702.27M
Cost of Goods Sold i	295.19M	102.02M
COGS % of Revenue i	11.7%	14.5%
Gross Profit i	2.23B	600.25M
Gross Margin i	88.3%	85.5%
Research & Development i	N/A	N/A
Operating Income (EBIT) i	496.39M	124.96M
Operating Margin i	19.7%	17.8%
EBITDA i	878.64M	170.94M
EBITDA Margin i	34.9%	24.3%
Pre-Tax Income i	414.05M	104.18M
Pre-Tax Income % of Revenue i	16.4%	14.8%
Income Tax i	104.27M	27.35M
Income Tax % of Revenue i	4.1%	3.9%
Net Income (Profit) i	309.78M	76.84M
Profit Margin i	12.3%	10.9%

Balance Sheet & Liquidity Metrics

Metric	SURAKSHA (2025)	QLL (2025)
Cash & Equivalents i	22.47M	43.10M
Total Current Assets i	471.53M	426.08M
Total Current Assets % of Revenue i	18.7%	60.7%
Total Current Liabilities i	427.17M	325.84M
Total Current Liabilities % of Revenue i	16.9%	46.4%
Long-Term Debt i	741.03M	308.61M
Long-Term Debt % of Revenue i	29.4%	43.9%
Total Shareholders Equity i	2.10B	927.82M
Retained Earnings i	1.54B	145.04M
Retained Earnings % of Revenue i	61.1%	20.7%
Property, Plant & Equipment i	1.38B	589.98M

Cash Flow Statement Comparison

Metric	SURAKSHA (2025)	QLL (2025)
Operating Cash Flow i	365.13M	58.03M
Operating Cash Flow % of Revenue i	14.5%	8.3%
Capital Expenditures i	-418.83M	-233.17M
Free Cash Flow i	213.35M	-128.53M
FCF Margin i	8.5%	-18.3%
Debt Repayment i	-28.11M	N/A
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	SURAKSHA	QLL
Shares Short i	N/A	N/A
Short Ratio i	N/A	N/A
Short % of Float i	N/A	N/A
Shares Outstanding i	52.08M	9.98M
Float Shares i	17.19M	3.60M
% Held by Insiders i	61.97%	65.77%
% Held by Institutions i	22.15%	0.00%
% Held by Public i	15.88%	34.23%

Dividend Analysis & Yield Comparison: Suraksha Diagnostic Ltd. vs Qualitek Labs Ltd.

Metric	SURAKSHA	QLL
Last 12-Month Dividend i	N/A	N/A
Last 12-Month Dividend Yield i	N/A	N/A
3-Year Avg Annual Dividend i	N/A	N/A
3-Year Avg Dividend Yield i	N/A	N/A
3-Year Total Dividends i	N/A	N/A
Ex-Dividend Date	N/A	N/A

Suraksha Diagnostic [SURAKSHA] vs Qualitek Labs [QLL] Detailed Stock Comparison

Suraksha Diagnostic Ltd.

Qualitek Labs Ltd.

TLDR: Quick Comparison Summary

Vital Metrics Comparison

Complete Suraksha Diagnostic Ltd. Investment Analysis: Compare with Industry Leaders

Ever Wonder Which Stock is Really the Better Pick?

What You'll Actually Learn (in Plain English)

💰 Which Stock is Cheaper

🏥 Which Company is Healthier

📈 Which Has Been Growing Faster

💵 Which Pays You Better

Suraksha Diagnostic Ltd. vs Qualitek Labs Ltd. Stock Performance Analysis

Performance Comparison

Short-term Returns

Long-term Returns

Performance & Financial Health Analysis: Suraksha Diagnostic Ltd. vs Qualitek Labs Ltd.

Valuation & Enterprise Metrics Analysis: Suraksha Diagnostic Ltd. vs Qualitek Labs Ltd.

Financial Statements Comparison: Suraksha Diagnostic Ltd. vs Qualitek Labs Ltd.

Financial Metrics

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

SURAKSHA (Annual)

SURAKSHA (Quarterly)

QLL (Annual)

Financial Statements Comparison

Income Statement

Balance Sheet & Liquidity Metrics

Cash Flow Statement Comparison

Income Statement

Balance Sheet & Liquidity Metrics

Cash Flow Statement Comparison

Short Interest & Institutional Ownership Analysis

Dividend Analysis & Yield Comparison: Suraksha Diagnostic Ltd. vs Qualitek Labs Ltd.

Metric	SURAKSHA (Sep 30, 2025)	QLL
Revenue/Sales i	787.29M	N/A
Cost of Goods Sold i	89.01M	N/A
COGS % of Revenue i	11.3%	-
Gross Profit i	698.28M	N/A
Gross Margin i	88.7%	-
Research & Development i	N/A	N/A
Operating Income (EBIT) i	141.76M	N/A
Operating Margin i	18.0%	-
EBITDA i	251.70M	N/A
EBITDA Margin i	32.0%	-
Pre-Tax Income i	120.47M	N/A
Pre-Tax Income % of Revenue i	15.3%	-
Income Tax i	32.19M	N/A
Income Tax % of Revenue i	4.1%	-
Net Income (Profit) i	88.28M	N/A
Profit Margin i	11.2%	-

Metric	SURAKSHA (Sep 30, 2025)	QLL
Cash & Equivalents i	21.07M	43.10M
Total Current Assets i	734.22M	426.08M
Total Current Assets % of Revenue i	93.3%	-
Total Current Liabilities i	417.79M	325.84M
Total Current Liabilities % of Revenue i	53.1%	-
Long-Term Debt i	1.02B	308.61M
Long-Term Debt % of Revenue i	129.7%	-
Total Shareholders Equity i	2.29B	927.82M
Retained Earnings i	N/A	145.04M
Retained Earnings % of Revenue i	0.0%	-
Property, Plant & Equipment i	2.71B	589.98M

Metric	SURAKSHA (Sep 30, 2025)	QLL
Operating Cash Flow i	148.52M	N/A
Operating Cash Flow % of Revenue i	18.9%	-
Capital Expenditures i	-123.19M	N/A
Free Cash Flow i	64.63M	N/A
FCF Margin i	8.2%	-
Debt Repayment i	-7.29M	N/A
Common Stock Repurchase i	N/A	N/A

Suraksha Diagnostic [SURAKSHA] vs Qualitek Labs [QLL] Detailed Stock Comparison

Suraksha Diagnostic Ltd.

Qualitek Labs Ltd.

TLDR: Quick Comparison Summary

Vital Metrics Comparison

Complete Suraksha Diagnostic Ltd. Investment Analysis: Compare with Industry Leaders

Ever Wonder Which Stock is Really the Better Pick?

What You'll Actually Learn (in Plain English)

💰 Which Stock is Cheaper

🏥 Which Company is Healthier

📈 Which Has Been Growing Faster

💵 Which Pays You Better

Suraksha Diagnostic Ltd. vs Qualitek Labs Ltd. Stock Performance Analysis

Performance Comparison

Short-term Returns

Long-term Returns

Performance & Financial Health Analysis: Suraksha Diagnostic Ltd. vs Qualitek Labs Ltd.

Valuation & Enterprise Metrics Analysis: Suraksha Diagnostic Ltd. vs Qualitek Labs Ltd.

Financial Statements Comparison: Suraksha Diagnostic Ltd. vs Qualitek Labs Ltd.

Financial Metrics Quarterly Annual

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

SURAKSHA (Annual)

SURAKSHA (Quarterly)

QLL (Annual)

Financial Statements Comparison

Income Statement

Balance Sheet & Liquidity Metrics

Cash Flow Statement Comparison

Income Statement

Balance Sheet & Liquidity Metrics

Cash Flow Statement Comparison

Short Interest & Institutional Ownership Analysis

Dividend Analysis & Yield Comparison: Suraksha Diagnostic Ltd. vs Qualitek Labs Ltd.

Financial Metrics